Trademark: 88804091
Status Date
Monday, September 18, 2023
Filing Date
Thursday, February 20, 2020
Published for Opposition
Tuesday, June 23, 2020
Abandoned Date
Monday, September 18, 2023
5 Syringes sold filled with pharmaceutical composition, namely, botulinum toxin type A for the treatment of wrinkles, botulinum toxin type B for the treatment of wrinkles, and influenza vaccination
10 Syringes for medical purposes and for injections; injection device for pharmaceuticals; modular components of medical syringes, namely, syringe barrels, syringe plungers, and injection needles
Sep 18, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 18, 2023
Abandonment - No Use Statement Filed
Mar 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2023
Sou Extension 5 Granted
Feb 9, 2023
Sou Extension 5 Filed
Feb 27, 2023
Case Assigned To Intent To Use Paralegal
Feb 9, 2023
Sou Teas Extension Received
Aug 17, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 15, 2022
Sou Extension 4 Granted
Aug 15, 2022
Sou Extension 4 Filed
Aug 15, 2022
Sou Teas Extension Received
Feb 17, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 15, 2022
Sou Extension 3 Granted
Feb 15, 2022
Sou Extension 3 Filed
Feb 15, 2022
Sou Teas Extension Received
Aug 19, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 17, 2021
Sou Extension 2 Granted
Aug 17, 2021
Sou Extension 2 Filed
Aug 17, 2021
Sou Teas Extension Received
Feb 19, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 17, 2021
Sou Extension 1 Granted
Feb 17, 2021
Sou Extension 1 Filed
Feb 17, 2021
Sou Teas Extension Received
Aug 18, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 23, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 23, 2020
Published For Opposition
Jun 3, 2020
Notification Of Notice Of Publication E-Mailed
May 15, 2020
Approved For Pub - Principal Register
May 11, 2020
Assigned To Examiner
Feb 25, 2020
New Application Office Supplied Data Entered
Feb 24, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24